U.S. health department officials explored potential restrictions on specific drugs within the selective serotonin reuptake inhibitor class of antidepressants, according ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE